Home Alzheimer’s Disease Analysis of Stage I EFHWTs Treatment Finds Event-Free Survival and Overall Survival...

Analysis of Stage I EFHWTs Treatment Finds Event-Free Survival and Overall Survival Rates Greater Than 95%

Data for stage I epithelial-predominant favorable-histology Wilms tumors (EFHWTs) reported greater than a 95% event-free survival rate and overall survival rate, supporting the utility of investigating the treatment of stage I EFHWTs with observation alone after nephrectomy, according to a recent study published in Cancer.

Specifically, the 4-year event-free survival (EFS) rate was 96.2% (95% CI, 92%-100%), while the 4-year overall survival (OS) rate was 100%. More, the EFS and OS rates did not statistically significantly differ with the age at diagnosis (<48 vs ≥48 months; P= .37) or treatment (EE4A vs observation only; P= .55).

“The current study examines the outcomes of all patients with stage I EFHWTs registered in a cooperative group clinical study to evaluate the feasibility of treating these patients without adjuvant chemotherapy through a retrospective review,” wrote…

Continue Reading to the Source

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Cancer and Mental Health Re-post : braincancer

Hello!I would like to thank everyone who participated in my survey these past few months! I received a tremendous response and I truly, truly...

I put my feelings in music. : braincancer

Song LinkHi amigos. My 2year old son has been battling cancer for nearly 6 months and this song is just a expression of my...

Podcast Episode Interviewing Brain Cancer Fighter & Survivor : braincancer

Hi all, we have a podcast called Making Headway that is meant as a support for brain injury survivors. My co-host, Eryn, and I...

How has COVID-19 affected the global cancer community? – IBTA

Save the date: Coalition Connection: COVID-19 on 4 February 06:30am PST/ 09:30am EST/ 02:30pm GMT/ 03:30pm CET On 4th February 2021, the Global Cancer Coalition Network...

Recent Comments